Is NMRA up or down today?
NMRA is down 1.53% today, last at 1.29. This stock moved -1.53% versus the prior close.
NMRA · NMRA
NMRA (NMRA) is trading at 1.29, down 1.53% on the session. NMRA sits at the 16% mark of its 52-week range, carries a 14-day RSI of 35, and trades below its 50-day average. Over the past month it is down 21.34%.
Leading the coverage: “Neumora Therapeutics Q2 2026 Earnings: Narrower Loss Beats Expectations, Shares Slip 3.96% - Quarterly Earnings - vinanet.vn” (Google News Earnings, 7d ago). NMRA is -3.01% since story.
NMRA trades on a trailing P/E of 9.1 and is running 21.55% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
NMRA is down 1.53% today, last at 1.29. This stock moved -1.53% versus the prior close.
Leading the coverage: “Neumora Therapeutics Q2 2026 Earnings: Narrower Loss Beats Expectations, Shares Slip 3.96% - Quarterly Earnings - vinanet.vn” (Google News Earnings, 7d ago). NMRA is -3.01% since story. Dominant story: NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials - Stocktwits (1 source, neutral) RSI is 35 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials - Stocktwits
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
BlackRock Inc. Buys Shares of 7,791,869 Neumora Therapeutics, Inc. $NMRA - MarketBeat
Neumora Therapeutics Q2 2026 Earnings: Narrower Loss Beats Expectations, Shares Slip 3.96% - Quarterly Earnings - vinanet.vn
Insiders Sold Neumora Therapeutics Prematurely At US$2.29 With Stock Trading Higher - simplywall.st